Novo

1 products tracked · names used in filings: Novo

Upcoming milestones

No upcoming milestones listed.

Recent milestones

Mon 22 Dec 2025🇺🇸 FDA approval

FDA approves Wegovy (semaglutide): new dosage form

Novo; NDA218316; New dosage form; tablet · source

Products

ProductStatusApproved
🇺🇸Wegovy
semaglutide
Approved2025-12-22

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.